Periprocedural Myocardial Infarction following Elective Percutaneous Coronary Interventions
- PMID: 39077696
- PMCID: PMC11262399
- DOI: 10.31083/j.rcm2309309
Periprocedural Myocardial Infarction following Elective Percutaneous Coronary Interventions
Abstract
The prognostic relevance of periprocedural myocardial infarction (PMI) in patients with chronic coronary syndrome undergoing percutaneous coronary intervention (PCI) is still matter of debate, particularly regarding the type (cardiac troponin or creatin kinase-MB) and different thresholds of biomarkers elevation, as the importance of associated ancillary criteria of ischemia or concomitant angiographic complications. There are still uncertainties regarding the value of PMI as event which is prognostically equivalent to spontaneous myocardial infarction or if it simply represents a marker of baseline risk, atherosclerotic burden and procedural complexity. In the present review, we will present the mechanisms and predictors of PMI occurring during PCI and potential treatment strategies to reduce its occurrence. We will also overview all commonly adopted definitions of PMI, which carry different prevalence and prognostic implications in daily practice and clinical trials. Finally, we will discuss the impact of different PMI definitions on the interpretation of trials results, emphasizing the importance of adequate endpoints selection in the planning and interpretation of clinical trials.
Keywords: chronic coronary syndrome; percutaneous coronary intervention; periprocedural myocardial infarction.
Copyright: © 2022 The Author(s). Published by IMR Press.
Conflict of interest statement
The authors declare no conflict of interest. Stefano De Servi is serving as one of the Editorial Board members of this journal. We declare that Stefano De Servi had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Federico Ronco.
Figures
References
-
- Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P, et al. Periprocedural myocardial infarction and injury in elective coronary stenting. European Heart Journal . 2018;39:1100–1109. - PubMed
-
- Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018) Circulation . 2018;138:e618–e651. - PubMed
-
- Valgimigli M, Leonardi S. Peri-procedural myocardial infarction and troponism: a quick journey through the land of confusion. Heart . 2012;98:1400–1401. - PubMed
-
- Jeremias A, Baim DS, Ho KKL, Chauhan M, Carrozza JP, Cohen DJ, et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. Journal of the American College of Cardiology . 2004;44:1210–1214. - PubMed
-
- Wang HY, Xu B, Dou K, Guan C, Song L, Huang Y, et al. Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI. JACC Cardiovasc Interv . 2021;14:1623–1634. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
